Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Tumor imaging and interferon-γ-inducible protein-10 gene transfer using a highly efficient transferrin-conjugated liposome system in mice.

Zhuo H, Peng Y, Yao Q, Zhou N, Zhou S, He J, Fang Y, Li X, Jin H, Lu X, Zhao Y.

Clin Cancer Res. 2013 Aug 1;19(15):4206-17. doi: 10.1158/1078-0432.CCR-12-3451. Epub 2013 Jun 12.

2.

Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.

Lai C, Yu X, Zhuo H, Zhou N, Xie Y, He J, Peng Y, Xie X, Luo G, Zhou S, Zhao Y, Lu X.

J Biomed Nanotechnol. 2014 Dec;10(12):3576-89.

PMID:
26000371
3.

The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer.

Wang Z, Yu Y, Dai W, Lu J, Cui J, Wu H, Yuan L, Zhang H, Wang X, Wang J, Zhang X, Zhang Q.

Biomaterials. 2012 Nov;33(33):8451-60. doi: 10.1016/j.biomaterials.2012.08.031. Epub 2012 Aug 31.

PMID:
22940213
4.

Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

Yang F, Gou M, Deng H, Yi T, Zhong Q, Wei Y, Zhao X.

Oncol Rep. 2012 Aug;28(2):668-76. doi: 10.3892/or.2012.1853. Epub 2012 Jun 6.

PMID:
22684947
5.

Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA.

Koppu S, Oh YJ, Edrada-Ebel R, Blatchford DR, Tetley L, Tate RJ, Dufès C.

J Control Release. 2010 Apr 19;143(2):215-21. doi: 10.1016/j.jconrel.2009.11.015. Epub 2009 Nov 26.

PMID:
19944722
6.

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.

Li X, Ding L, Xu Y, Wang Y, Ping Q.

Int J Pharm. 2009 May 21;373(1-2):116-23. doi: 10.1016/j.ijpharm.2009.01.023. Epub 2009 Feb 4.

PMID:
19429296
7.

Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model.

Mei K, Wang L, Tian L, Yu J, Zhang Z, Wei Y.

J Exp Clin Cancer Res. 2008 Nov 5;27:63. doi: 10.1186/1756-9966-27-63.

8.

Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts.

Shan L, Wang S, Sridhar R, Bhujwalla ZM, Wang PC.

Mol Imaging. 2007 Mar-Apr;6(2):85-95.

PMID:
17445503
9.
10.

Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.

Yang X, Chu Y, Wang Y, Zhang R, Xiong S.

J Leukoc Biol. 2006 Dec;80(6):1434-44. Epub 2006 Sep 15.

PMID:
16980511
11.
12.

Antitumoral activity of transferrin-lipoplexes carrying the IL-12 gene in the treatment of colon cancer.

Tros De Ilarduya C, Buñuales M, Qian C, Düzgüneş N.

J Drug Target. 2006 Sep;14(8):527-35.

PMID:
17050119
13.

Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles.

Fu JY, Blatchford DR, Tetley L, Dufès C.

J Control Release. 2009 Dec 3;140(2):95-9. doi: 10.1016/j.jconrel.2009.08.017. Epub 2009 Aug 23.

PMID:
19709637
14.

Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.

Nomura T, Yasuda K, Yamada T, Okamoto S, Mahato RI, Watanabe Y, Takakura Y, Hashida M.

Gene Ther. 1999 Jan;6(1):121-9.

15.

Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles.

Pun SH, Tack F, Bellocq NC, Cheng J, Grubbs BH, Jensen GS, Davis ME, Brewster M, Janicot M, Janssens B, Floren W, Bakker A.

Cancer Biol Ther. 2004 Jul;3(7):641-50. Epub 2004 Jul 9.

PMID:
15136766
16.

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.

J Control Release. 2001 Jul 6;74(1-3):95-113.

PMID:
11489487
17.

p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.

Nakase M, Inui M, Okumura K, Kamei T, Nakamura S, Tagawa T.

Mol Cancer Ther. 2005 Apr;4(4):625-31.

18.

LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.

Yan Z, Wang F, Wen Z, Zhan C, Feng L, Liu Y, Wei X, Xie C, Lu W.

J Control Release. 2012 Jan 10;157(1):118-25. doi: 10.1016/j.jconrel.2011.07.034. Epub 2011 Jul 29.

PMID:
21827801
19.

Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.

Yang F, Li Z, Deng H, Yang H, Yan F, Qian Z, Chen L, Wei Y, Zhao X.

Oncology. 2008;75(3-4):137-44. doi: 10.1159/000158664. Epub 2008 Sep 29.

PMID:
18824876
20.

Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.

Huang H, Yu H, Tang G, Wang Q, Li J.

Biomaterials. 2010 Mar;31(7):1830-8. doi: 10.1016/j.biomaterials.2009.11.012. Epub 2009 Nov 25.

PMID:
19942284

Supplemental Content

Support Center